34
Participants
Start Date
December 13, 2018
Primary Completion Date
October 21, 2021
Study Completion Date
July 21, 2022
Abatacept
Subcutaneous abatacept every weeks during 3 months
Placebos
Subcutaneous placebo every week during 3 months
CHRU de Brest, Brest
CH Le Mans, Le Mans
CH de Morlaix, Morlaix
CH St-Malo, St-Malo
CHU Strasbourg, Strasbourg
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
University Hospital, Brest
OTHER